Screening for Islet Autoantibodies in the Israeli Paediatric General Population for Detection of Pre-symptomatic Type-1 Diabetes Mellitus

ישראלמגייס משתתפים

מצבים רפואיים

Type1diabetes

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

Soroka Medical Center, Beersheba, Israel
Contact: Study coordinator (Eli Hershkovitz, Prof) · EliH@clalit.org.il
Contact: Study coordinator (Eli Hershkovitz, Prof)
Rambam Medical Center, Haifa, Israel
Contact: Study coordinator (Naim Shehadeh, Prof) · n_shehadeh@rambam.health.gov.il
Contact: Study coordinator (Naim Shehadeh, Prof)
Hadassah medical Center, Jerusalem, Israel
Contact: Study coordinator (David Zangen, Dr) · ZANGEND@hadassah.org.il
Contact: Study coordinator (David Zangen, Dr)
Child Health Centers all over Israel (clalit Health Services), Petah Tikva, Israel
Contact: Study coordinator (Avner Cohen, Prof) · hermanc@tauex.tau.ac.il · 972-523-870-827
Contact: Study coordinator (Avner Cohen, Prof)
Schneider Children Medical Center of Israel, Petah Tikva, Israel
Contact: Study coordinator (Alona Hamou, MSc) · alonah@clalit.org.il · 972-545-950-277
Contact: Study coordinator (Moshe Phillip, Prof)
Contact: Study coordinator (Tal Oron, Dr.)
Sheba Medical Center, Ramat Gan, Israel
Contact: Study coordinator (Orit Hamiel, Prof) · Orit.Hamiel@sheba.health.gov.il
Contact: Study coordinator (Orit Hamiel, Prof)
Dana-Duek children's hospital, Tel Aviv, Israel
Contact: Study coordinator (Yael Lebenthal, Prof) · yaelleb@tlvmc.gov.il
Contact: Study coordinator (Yael Lebenthal, Prof)

מובילי המחקר